-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, EhA3SBX+zzY3sWZAyGlrB+7n4CUqaTr79v76qQrjTJQjme7jUVhzbAbL2Fl7oLiV 482nYDTkvuoQebuk3dvPRg== 0000950152-00-008270.txt : 20001201 0000950152-00-008270.hdr.sgml : 20001201 ACCESSION NUMBER: 0000950152-00-008270 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20001128 ITEM INFORMATION: FILED AS OF DATE: 20001130 FILER: COMPANY DATA: COMPANY CONFORMED NAME: N-VIRO INTERNATIONAL CORP CENTRAL INDEX KEY: 0000904896 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 341741211 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: SEC FILE NUMBER: 000-21802 FILM NUMBER: 781247 BUSINESS ADDRESS: STREET 1: 3450 W CENTRAL AVE STREET 2: STE 328 CITY: TOLEDO STATE: OH ZIP: 43606 BUSINESS PHONE: 4195356374 MAIL ADDRESS: STREET 1: 3450 WEST CENTRAL AVENUE SUITE 328 CITY: TOLEDO STATE: OH ZIP: 43606 8-K 1 l85230ae8-k.txt N-VIRO INTERNATIONAL CORPORATION FORM 8-K 1 ================================================================================ - -------------------------------------------------------------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 -------------- FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED): NOVEMBER 28, 2000 N-VIRO INTERNATIONAL CORPORATION (EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER) DELAWARE 0-21802 34-1741211 (STATE OR OTHER JURISDICTION (COMMISSION (IRS EMPLOYER OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.) 3450 W. CENTRAL AVENUE, SUITE 328 TOLEDO, OHIO 43606 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE: (419) 535-6374 - -------------------------------------------------------------------------------- ================================================================================ 2 ITEM 5. OTHER EVENTS On November 28, 2000, N-Viro International Corporation (the "Company") filed an action in the United States District Court for the Northern District of Ohio, Western Division against Hydropress Environmental Services, Inc. ("Hydropress"). This suit involves to certain matters related to Hydropress' ownership and sale of certain shares of the Company's voting, common stock. In December of 1994, Hydropress received 62,500 shares of the Company's voting, common stock (the "Company Stock") pursuant to the terms of a Licensing Agreement dated as of December 30, 1994 by and among the Company, New England N-Viro, Inc. and Hydropress (the "1994 Agreement"). The 1994 Agreement included, among other things, a commitment on the part of the Company that Hydropress would receive as proceeds from the sale of any of its shares of Company Stock proceeds of at least $6.00 per share. On February 15, 2000, Hydropress and the Company entered into a new agreement related to the Company Stock held by Hydropress and the Company's guarantee that Hydropress would receive proceeds from the sale of such stock of at least $6.00 per share. A copy of this letter is attached hereto as Exhibit 99.1 and incorporated herein by reference. The Company understands the letter agreement dated February 15, 2000 to excuse it entirely from its obligation to guarantee Hydropress' receipt of proceeds of at least $6.00 per share from the sale of the Company Stock. This is consistent with the position taken in the Company's public filings under and pursuant to the terms of the Securities Exchange Act of 1934 and the rules and regulations promulgated thereunder, as well as the Company's audited financial statements. In late September of 2000, representatives of Hydropress contacted the Company and informed the Company that Hydropress maintains that the $6.00 per share guarantee of proceeds in favor of Hydropress is still in effect. The Board of Directors of the Company, following discussion of this issue with the Company's legal counsel, continues to maintain that Hydropress has waived its right to the $6.00 per share guarantee of proceeds pursuant to the terms of the February 15, 2000 letter agreement. In order to resolve this issue and ensure that the Company is accurately reporting the effect of the February 15, 2000 letter agreement in its filings with the Securities and Exchange Commission as well as in its financial statements, the Company filed the above-referenced action in federal district court in Toledo seeking a declaration from the Court that the Company's position with respect to the expiration of the $6.00 per share guarantee of proceeds is accurate and correct SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. N-VIRO INTERNATIONAL CORPORATION Dated: November 30, 2000 By: /s/ James K. McHugh ----------------------------- ----------------------------- James K. McHugh Chief Financial Officer EX-99.1 2 l85230aex99-1.txt PRESS RELEASE EXHIBIT 99.1 1 EXHIBIT 99.1 ------------ [letterhead] HYDROPRESS ENVIRONMENTAL SERVICES, INC. ---------------------------- February 15, 2000 Dr. Terry J. Logan, President N-Viro International Corp. 3450 W. Central Avenue Suite 328 Toledo, OH 43606 Dear Terry: This will confirm our conversations regarding the Common Stock of N-Viro held by Hydropress and acquired pursuant to our agreement of December 30, 1994, as amended by our Settlement Agreement effective as of March 22, 1999 (as so amended the "Agreement"). 1. You will instruct your transfer agent that all stock held by Hydropress is no longer subject to any restrictions on transfer. 2. By signing below you waive the currently effective 18-month period during which Hydropress was to defer any stock sales to permit the sales described below. 3. Hydropress may seek to sell initially up to 15,000 shares of N-Viro Common Stock monthly. Offers for sale in excess of the 15,000 shares shall in each case require the prior approval of N-Viro given by fax signed by you. 4. As to any sales by Hydropress under this arrangement, N-Viro shall be released from its minimum guarantee obligations as set forth in the Agreement. If the foregoing is acceptable, please sign below and return to my by facsimile. Very truly yours, /s/ Dana G. Taylor --------------------------- Dana G. Taylor President The foregoing is agreed to. N-VIRO INTERNATIONAL CORP. By: /s/ Terry J. Logan --------------------------------- Terry J. Logan, President Dated: February 15, 2000 [letterhead] 81 WEST STREET WEST HATFIELD, MASSACHUSETTS 01088 413-247-9656 FAX 413-247-9401 -----END PRIVACY-ENHANCED MESSAGE-----